Morningstar Rating

Stock Research and Analysis

by Erin Lash, CFA

Bulls Say

Mead Johnson generates over 70% of its sales from Asia and Latin America, positioning the firm to benefit from rising middle-class incomes in emerging markets.
The network of pediatricians recommending Mead Johnson's branded products provides a pipeline of customers who will likely make repeat purchases.
Mead Johnson has planted seeds in emerging markets, like India, which currently generate minimal sales and profits, but hold significant long-term potential as a result of shifting consumer behaviors, wage growth, and rising female labor participation rates. Read more 

Bears Say

Lackluster growth in birth rates and higher breastfeeding rates could constrain volume growth in mature and developing regions over the long term.
The Chinese government has adopted an active role in monitoring category pricing and supporting local manufacturers, which could constrain pricing power in the region.
Increased competition from local brands and private-label products, along with education programs advocating for breastfeeding, could reduce Mead Johnson’s brand loyalty and ability to maintain its premium pricing. Read more 


We have assigned Mead Johnson a Standard stewardship rating. We think the executive team has done a good job increasing shareholder value since the firm began operating as an independent entity. Kasper Jakobsen assumed the CEO role after Stephen Golsby,  Read more 


Mead Johnson Nutrition is a supplier of infant and children's nutrition products globally, with its Enfamil brand as the primary source of revenue. Infant nutrition products   Read more 

3 Big Moat Rating Changes From 2014 
Watch more 

Premium Membership

View all of our analyst reports with a free trial to Premium.